ResearcherJikei University School of MedicineActive in the last 2 years
Kyohei Abe
Matched on ORCID iD 0000-0001-8836-0112; OpenAlex author ID A5102832970. Sources: OpenAlex.
Their work
- Papers
- 10
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 3 papers · 2024: 1 paper · 2025: 3 papers
Papers 10
- The preoperative cachexia index predicts outcomes after pancreatic resection for resectable pancreatic cancer. Co-author DOI 10.1007/s00595-025-03088-w↗
- Timing of TS1 adjuvant chemotherapy as a prognostic factor in recurrent pancreatic cancer after surgery. Co-author DOI 10.1016/j.suronc.2024.102179↗
- Prognostic Impact of a Decrease in Serum Carbohydrate Antigen 19-9 Levels After Preoperative Therapy for 4 Months or More for Borderline Resectable Pancreatic … Co-author DOI 10.1177/00031348241278016↗
- Effect of Risk Factor Score on Early Recurrence After Pancreatectomy for Invasive Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.16968↗
- Superior mesenteric vein/portal vein contact in preoperative imaging indicates biological malignancy in anatomically resectable pancreatic cancer. Co-author DOI 10.1016/j.suronc.2023.101998↗
- The Impact of Fibrinogen to Prognostic Nutritional Index Rate on Prognosis of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1177/00031348231204912↗
- D1 Distal Pancreatectomy for Left-sided Pancreatic Ductal Adenocarcinoma Is Justifiable: A Propensity-score Matched Multicenter Study. Co-author DOI 10.21873/anticanres.16150↗
- Effects of an enteral nutrient-rich therapy with omega-3 fatty acids in patients with unresectable or recurrent biliary tract cancer or pancreatic cancer durin… Co-author DOI 10.1007/s12032-021-01625-4↗
- Impact of osteopenia on surgical and oncological outcomes in patients with pancreatic cancer. Co-author DOI 10.1007/s10147-021-01986-w↗
- Effects of ω-3 Fatty Acid Supplementation in Patients with Bile Duct or Pancreatic Cancer Undergoing Chemotherapy. Co-author DOI 10.21873/anticanres.12485↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Toru Ikegami · 9 shared papers, 2021–2025 · strength 1.68
- Paper Timing of TS1 adjuvant chemotherapy as a prognostic factor in recurrent pancreatic cancer after surgery. DOI 10.1016/j.suronc.2024.102179↗
- Paper Prognostic Impact of a Decrease in Serum Carbohydrate Antigen 19-9 Levels After Preoperative Therapy for 4 Months or Mo… DOI 10.1177/00031348241278016↗
- Paper The preoperative cachexia index predicts outcomes after pancreatic resection for resectable pancreatic cancer. DOI 10.1007/s00595-025-03088-w↗
- Ryoga Hamura · 8 shared papers, 2022–2025 · strength 1.54
- Paper Timing of TS1 adjuvant chemotherapy as a prognostic factor in recurrent pancreatic cancer after surgery. DOI 10.1016/j.suronc.2024.102179↗
- Paper Prognostic Impact of a Decrease in Serum Carbohydrate Antigen 19-9 Levels After Preoperative Therapy for 4 Months or Mo… DOI 10.1177/00031348241278016↗
- Paper The preoperative cachexia index predicts outcomes after pancreatic resection for resectable pancreatic cancer. DOI 10.1007/s00595-025-03088-w↗
- Kenei Furukawa · 8 shared papers, 2021–2025 · strength 1.52
- Paper Timing of TS1 adjuvant chemotherapy as a prognostic factor in recurrent pancreatic cancer after surgery. DOI 10.1016/j.suronc.2024.102179↗
- Paper Prognostic Impact of a Decrease in Serum Carbohydrate Antigen 19-9 Levels After Preoperative Therapy for 4 Months or Mo… DOI 10.1177/00031348241278016↗
- Paper The preoperative cachexia index predicts outcomes after pancreatic resection for resectable pancreatic cancer. DOI 10.1007/s00595-025-03088-w↗
- Koichiro Haruki · 8 shared papers, 2018–2025 · strength 1.44
- Paper Timing of TS1 adjuvant chemotherapy as a prognostic factor in recurrent pancreatic cancer after surgery. DOI 10.1016/j.suronc.2024.102179↗
- Paper Prognostic Impact of a Decrease in Serum Carbohydrate Antigen 19-9 Levels After Preoperative Therapy for 4 Months or Mo… DOI 10.1177/00031348241278016↗
- Paper The preoperative cachexia index predicts outcomes after pancreatic resection for resectable pancreatic cancer. DOI 10.1007/s00595-025-03088-w↗
- Yoshihiro Shirai · 8 shared papers, 2021–2025 · strength 1.43
- Paper Timing of TS1 adjuvant chemotherapy as a prognostic factor in recurrent pancreatic cancer after surgery. DOI 10.1016/j.suronc.2024.102179↗
- Paper The preoperative cachexia index predicts outcomes after pancreatic resection for resectable pancreatic cancer. DOI 10.1007/s00595-025-03088-w↗
- Paper Effect of Risk Factor Score on Early Recurrence After Pancreatectomy for Invasive Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.16968↗
- Masashi Tsunematsu · 7 shared papers, 2023–2025 · strength 1.39
- Paper Timing of TS1 adjuvant chemotherapy as a prognostic factor in recurrent pancreatic cancer after surgery. DOI 10.1016/j.suronc.2024.102179↗
- Paper Prognostic Impact of a Decrease in Serum Carbohydrate Antigen 19-9 Levels After Preoperative Therapy for 4 Months or Mo… DOI 10.1177/00031348241278016↗
- Paper The preoperative cachexia index predicts outcomes after pancreatic resection for resectable pancreatic cancer. DOI 10.1007/s00595-025-03088-w↗
- Shinji Onda · 7 shared papers, 2018–2025 · strength 1.22
- Paper Prognostic Impact of a Decrease in Serum Carbohydrate Antigen 19-9 Levels After Preoperative Therapy for 4 Months or Mo… DOI 10.1177/00031348241278016↗
- Paper The preoperative cachexia index predicts outcomes after pancreatic resection for resectable pancreatic cancer. DOI 10.1007/s00595-025-03088-w↗
- Paper Effect of Risk Factor Score on Early Recurrence After Pancreatectomy for Invasive Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.16968↗
- Michinori Matsumoto · 6 shared papers, 2021–2025 · strength 1.12
- Paper Prognostic Impact of a Decrease in Serum Carbohydrate Antigen 19-9 Levels After Preoperative Therapy for 4 Months or Mo… DOI 10.1177/00031348241278016↗
- Paper The preoperative cachexia index predicts outcomes after pancreatic resection for resectable pancreatic cancer. DOI 10.1007/s00595-025-03088-w↗
- Paper Effect of Risk Factor Score on Early Recurrence After Pancreatectomy for Invasive Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.16968↗
- Takeshi Gocho · 5 shared papers, 2018–2025 · strength 0.79
- Paper Timing of TS1 adjuvant chemotherapy as a prognostic factor in recurrent pancreatic cancer after surgery. DOI 10.1016/j.suronc.2024.102179↗
- Paper D1 Distal Pancreatectomy for Left-sided Pancreatic Ductal Adenocarcinoma Is Justifiable: A Propensity-score Matched Mul… DOI 10.21873/anticanres.16150↗
- Paper Superior mesenteric vein/portal vein contact in preoperative imaging indicates biological malignancy in anatomically re… DOI 10.1016/j.suronc.2023.101998↗
- Tadashi Uwagawa · 4 shared papers, 2018–2025 · strength 0.61
- Paper The preoperative cachexia index predicts outcomes after pancreatic resection for resectable pancreatic cancer. DOI 10.1007/s00595-025-03088-w↗
- Paper Superior mesenteric vein/portal vein contact in preoperative imaging indicates biological malignancy in anatomically re… DOI 10.1016/j.suronc.2023.101998↗
- Paper Effects of an enteral nutrient-rich therapy with omega-3 fatty acids in patients with unresectable or recurrent biliary… DOI 10.1007/s12032-021-01625-4↗
- Yoshiaki Tanji · 3 shared papers, 2023–2024 · strength 0.51
- Paper Effect of Risk Factor Score on Early Recurrence After Pancreatectomy for Invasive Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.16968↗
- Paper The Impact of Fibrinogen to Prognostic Nutritional Index Rate on Prognosis of Pancreatic Ductal Adenocarcinoma. DOI 10.1177/00031348231204912↗
- Paper Superior mesenteric vein/portal vein contact in preoperative imaging indicates biological malignancy in anatomically re… DOI 10.1016/j.suronc.2023.101998↗
- Hironori Shiozaki · 3 shared papers, 2022–2024 · strength 0.50
- Paper Effect of Risk Factor Score on Early Recurrence After Pancreatectomy for Invasive Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.16968↗
- Paper D1 Distal Pancreatectomy for Left-sided Pancreatic Ductal Adenocarcinoma Is Justifiable: A Propensity-score Matched Mul… DOI 10.21873/anticanres.16150↗
- Paper Effects of an enteral nutrient-rich therapy with omega-3 fatty acids in patients with unresectable or recurrent biliary… DOI 10.1007/s12032-021-01625-4↗
- Shuichi Fujioka · 2 shared papers, 2023–2025 · strength 0.40
- Paper Timing of TS1 adjuvant chemotherapy as a prognostic factor in recurrent pancreatic cancer after surgery. DOI 10.1016/j.suronc.2024.102179↗
- Paper D1 Distal Pancreatectomy for Left-sided Pancreatic Ductal Adenocarcinoma Is Justifiable: A Propensity-score Matched Mul… DOI 10.21873/anticanres.16150↗
- Taro Sakamoto · 3 shared papers, 2018–2023 · strength 0.40
- Paper D1 Distal Pancreatectomy for Left-sided Pancreatic Ductal Adenocarcinoma Is Justifiable: A Propensity-score Matched Mul… DOI 10.21873/anticanres.16150↗
- Paper Superior mesenteric vein/portal vein contact in preoperative imaging indicates biological malignancy in anatomically re… DOI 10.1016/j.suronc.2023.101998↗
- Paper Effects of ω-3 Fatty Acid Supplementation in Patients with Bile Duct or Pancreatic Cancer Undergoing Chemotherapy. DOI 10.21873/anticanres.12485↗
- Yosuke Igarashi · 2 shared papers, 2023–2025 · strength 0.39
- Mitsuru Yanagaki · 2 shared papers, 2023 · strength 0.32
- Paper The Impact of Fibrinogen to Prognostic Nutritional Index Rate on Prognosis of Pancreatic Ductal Adenocarcinoma. DOI 10.1177/00031348231204912↗
- Paper Superior mesenteric vein/portal vein contact in preoperative imaging indicates biological malignancy in anatomically re… DOI 10.1016/j.suronc.2023.101998↗
- Tadashi Uwagawa · 1 shared paper, 2025 · strength 0.25
- Norimitsu Okui · 1 shared paper, 2025 · strength 0.22
- Tomohiko Taniai · 1 shared paper, 2023 · strength 0.15
- Katsuhiko K. Yanaga · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.